跳至主要内容
临床试验/IRCT2013113015597N1
IRCT2013113015597N1已完成2 期

Comparison of effectiveness of Tadalafil versus placebo on lower urinary tract symptoms in male patients with ureteral stent, A randomized controlled trial

Tabriz University of Medical Sciences0 个研究点目标入组 80 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
15 years 至 70 years(—)
性别
Male

入选标准

  • Male patients (+15 years) that underwent unilateral ureteral stenting.
  • Exclusion criteria: Patient's refusal of study; high blood pressure; history of heart disease; history of respiratory disease; history of stroke; hypotension (systolic blood pressure less than 90 mmHg); hepatic and renal failure; history of retinitis pigmentosa; severe headache; consumption of nitrate drugs and a positive urine culture

排除标准

  • 未提供

研究者

相似试验

Efficacy of Tadalafil on Lower Urinary tract... | 临床试验